新型コロナウイルス（COVID-19）治療薬の世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Novel Coronavirus (COVID-19) Drugs Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0804-16189 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、105ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、新型コロナウイルス（COVID-19）治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。新型コロナウイルス（COVID-19）治療薬の種類別市場規模（ワクチン、錠剤）、用途別市場規模（大人（非妊婦）、妊婦、子供、年配）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：National Institute of Allergy and Infectious Diseases、Gilead、Philipps University Marburg Medical Center、King Abdullah International Medical Research Center、Novavax、CanSino Biologics、Entos Pharmaceuticals、SAB Biotherapeutics、Naval Medical Research Center、Inovio ・地域別グローバル市場分析 2015年-2020年 ・新型コロナウイルス（COVID-19）治療薬の北米市場（アメリカ、カナダ、メキシコ） ・新型コロナウイルス（COVID-19）治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・新型コロナウイルス（COVID-19）治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・新型コロナウイルス（COVID-19）治療薬の南米市場（ブラジル、アルゼンチン） ・新型コロナウイルス（COVID-19）治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ワクチン、錠剤 ・用途別分析：大人（非妊婦）、妊婦、子供、年配 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The Novel Coronavirus (COVID-19) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Novel Coronavirus (COVID-19) Drugs sales will be xx in 2020 from Novel Coronavirus (COVID-19) Drugs million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Novel Coronavirus (COVID-19) Drugs market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Novel Coronavirus (COVID-19) Drugs industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Novel Coronavirus (COVID-19) Drugs and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Novel Coronavirus (COVID-19) Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Novel Coronavirus (COVID-19) Drugs market has been segmented into:
Vaccine
Tablet

By Application, Novel Coronavirus (COVID-19) Drugs has been segmented into:
Adults (Non-pregnant)
Pregnant Women
Children
Olders

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Novel Coronavirus (COVID-19) Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Novel Coronavirus (COVID-19) Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Novel Coronavirus (COVID-19) Drugs market.

The report offers in-depth assessment of the growth and other aspects of the Novel Coronavirus (COVID-19) Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Novel Coronavirus (COVID-19) Drugs Market Share Analysis
Novel Coronavirus (COVID-19) Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Novel Coronavirus (COVID-19) Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Novel Coronavirus (COVID-19) Drugs sales, revenue and market share for each player covered in this report.

The major players covered in Novel Coronavirus (COVID-19) Drugs are:
National Institute of Allergy and Infectious Diseases
Gilead
Philipps University Marburg Medical Center
King Abdullah International Medical Research Center
Novavax
CanSino Biologics
Entos Pharmaceuticals
SAB Biotherapeutics
Naval Medical Research Center
Inovio

レポート目次

---

1 Novel Coronavirus (COVID-19) Drugs Market Overview
1.1 Product Overview and Scope of Novel Coronavirus (COVID-19) Drugs
1.2 Classification of Novel Coronavirus (COVID-19) Drugs by Type
1.2.1 Global Novel Coronavirus (COVID-19) Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Novel Coronavirus (COVID-19) Drugs Revenue Market Share by Type in 2019
1.2.3 Vaccine
1.2.4 Tablet
1.3 Global Novel Coronavirus (COVID-19) Drugs Market by Application
1.3.1 Overview: Global Novel Coronavirus (COVID-19) Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Adults (Non-pregnant)
1.3.3 Pregnant Women
1.3.4 Children
1.3.5 Olders
1.4 Global Novel Coronavirus (COVID-19) Drugs Market by Regions
1.4.1 Global Novel Coronavirus (COVID-19) Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Novel Coronavirus (COVID-19) Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Novel Coronavirus (COVID-19) Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Novel Coronavirus (COVID-19) Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Novel Coronavirus (COVID-19) Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Novel Coronavirus (COVID-19) Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Novel Coronavirus (COVID-19) Drugs Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Novel Coronavirus (COVID-19) Drugs Industry Impact
1.5.1 COVID-19 Potential Implications for the Novel Coronavirus (COVID-19) Drugs
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Novel Coronavirus (COVID-19) Drugs
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 National Institute of Allergy and Infectious Diseases
2.1.1 National Institute of Allergy and Infectious Diseases Details
2.1.2 National Institute of Allergy and Infectious Diseases Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 National Institute of Allergy and Infectious Diseases SWOT Analysis
2.1.4 National Institute of Allergy and Infectious Diseases Product and Services
2.1.5 National Institute of Allergy and Infectious Diseases Novel Coronavirus (COVID-19) Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Gilead
2.2.1 Gilead Details
2.2.2 Gilead Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Gilead SWOT Analysis
2.2.4 Gilead Product and Services
2.2.5 Gilead Novel Coronavirus (COVID-19) Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Philipps University Marburg Medical Center
2.3.1 Philipps University Marburg Medical Center Details
2.3.2 Philipps University Marburg Medical Center Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Philipps University Marburg Medical Center SWOT Analysis
2.3.4 Philipps University Marburg Medical Center Product and Services
2.3.5 Philipps University Marburg Medical Center Novel Coronavirus (COVID-19) Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 King Abdullah International Medical Research Center
2.4.1 King Abdullah International Medical Research Center Details
2.4.2 King Abdullah International Medical Research Center Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 King Abdullah International Medical Research Center SWOT Analysis
2.4.4 King Abdullah International Medical Research Center Product and Services
2.4.5 King Abdullah International Medical Research Center Novel Coronavirus (COVID-19) Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novavax
2.5.1 Novavax Details
2.5.2 Novavax Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novavax SWOT Analysis
2.5.4 Novavax Product and Services
2.5.5 Novavax Novel Coronavirus (COVID-19) Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 CanSino Biologics
2.6.1 CanSino Biologics Details
2.6.2 CanSino Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 CanSino Biologics SWOT Analysis
2.6.4 CanSino Biologics Product and Services
2.6.5 CanSino Biologics Novel Coronavirus (COVID-19) Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Entos Pharmaceuticals
2.7.1 Entos Pharmaceuticals Details
2.7.2 Entos Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Entos Pharmaceuticals SWOT Analysis
2.7.4 Entos Pharmaceuticals Product and Services
2.7.5 Entos Pharmaceuticals Novel Coronavirus (COVID-19) Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 SAB Biotherapeutics
2.8.1 SAB Biotherapeutics Details
2.8.2 SAB Biotherapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 SAB Biotherapeutics SWOT Analysis
2.8.4 SAB Biotherapeutics Product and Services
2.8.5 SAB Biotherapeutics Novel Coronavirus (COVID-19) Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.9 Naval Medical Research Center
2.9.1 Naval Medical Research Center Details
2.9.2 Naval Medical Research Center Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Naval Medical Research Center SWOT Analysis
2.9.4 Naval Medical Research Center Product and Services
2.9.5 Naval Medical Research Center Novel Coronavirus (COVID-19) Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.10 Inovio
2.10.1 Inovio Details
2.10.2 Inovio Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Inovio SWOT Analysis
2.10.4 Inovio Product and Services
2.10.5 Inovio Novel Coronavirus (COVID-19) Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Novel Coronavirus (COVID-19) Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Novel Coronavirus (COVID-19) Drugs Players Market Share
3.2.2 Top 10 Novel Coronavirus (COVID-19) Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Novel Coronavirus (COVID-19) Drugs Revenue and Market Share by Regions
4.2 North America Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
5 North America Novel Coronavirus (COVID-19) Drugs Revenue by Countries
5.1 North America Novel Coronavirus (COVID-19) Drugs Revenue by Countries (2015-2020)
5.2 USA Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
6 Europe Novel Coronavirus (COVID-19) Drugs Revenue by Countries
6.1 Europe Novel Coronavirus (COVID-19) Drugs Revenue by Countries (2015-2020)
6.2 Germany Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
6.4 France Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Novel Coronavirus (COVID-19) Drugs Revenue by Countries
7.1 Asia-Pacific Novel Coronavirus (COVID-19) Drugs Revenue by Countries (2015-2020)
7.2 China Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
7.5 India Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
8 South America Novel Coronavirus (COVID-19) Drugs Revenue by Countries
8.1 South America Novel Coronavirus (COVID-19) Drugs Revenue by Countries (2015-2020)
8.2 Brazil Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Novel Coronavirus (COVID-19) Drugs by Countries
9.1 Middle East & Africa Novel Coronavirus (COVID-19) Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Novel Coronavirus (COVID-19) Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Novel Coronavirus (COVID-19) Drugs Market Forecast by Type (2019-2024)
10.3 Vaccine Revenue Growth Rate (2015-2025)
10.4 Tablet Revenue Growth Rate (2015-2025)
11 Global Novel Coronavirus (COVID-19) Drugs Market Segment by Application
11.1 Global Novel Coronavirus (COVID-19) Drugs Revenue Market Share by Application (2015-2020)
11.2 Novel Coronavirus (COVID-19) Drugs Market Forecast by Application (2019-2024)
11.3 Adults (Non-pregnant) Revenue Growth (2015-2020)
11.4 Pregnant Women Revenue Growth (2015-2020)
11.5 Children Revenue Growth (2015-2020)
11.6 Olders Revenue Growth (2015-2020)
12 Global Novel Coronavirus (COVID-19) Drugs Market Size Forecast (2021-2025)
12.1 Global Novel Coronavirus (COVID-19) Drugs Market Size Forecast (2021-2025)
12.2 Global Novel Coronavirus (COVID-19) Drugs Market Forecast by Regions (2021-2025)
12.3 North America Novel Coronavirus (COVID-19) Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Novel Coronavirus (COVID-19) Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Novel Coronavirus (COVID-19) Drugs Revenue Market Forecast (2021-2025)
12.6 South America Novel Coronavirus (COVID-19) Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Novel Coronavirus (COVID-19) Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Novel Coronavirus (COVID-19) Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Novel Coronavirus (COVID-19) Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Novel Coronavirus (COVID-19) Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Novel Coronavirus (COVID-19) Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Novel Coronavirus (COVID-19) Drugs Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. National Institute of Allergy and Infectious Diseases Corporate Information, Location and Competitors
Table 7. National Institute of Allergy and Infectious Diseases Novel Coronavirus (COVID-19) Drugs Major Business
Table 8. National Institute of Allergy and Infectious Diseases Novel Coronavirus (COVID-19) Drugs Total Revenue (USD Million) (2017-2018)
Table 9. National Institute of Allergy and Infectious Diseases SWOT Analysis
Table 10. National Institute of Allergy and Infectious Diseases Novel Coronavirus (COVID-19) Drugs Product and Solutions
Table 11. National Institute of Allergy and Infectious Diseases Novel Coronavirus (COVID-19) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Gilead Corporate Information, Location and Competitors
Table 13. Gilead Novel Coronavirus (COVID-19) Drugs Major Business
Table 14. Gilead Novel Coronavirus (COVID-19) Drugs Total Revenue (USD Million) (2018-2019)
Table 15. Gilead SWOT Analysis
Table 16. Gilead Novel Coronavirus (COVID-19) Drugs Product and Solutions
Table 17. Gilead Novel Coronavirus (COVID-19) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Philipps University Marburg Medical Center Corporate Information, Location and Competitors
Table 19. Philipps University Marburg Medical Center Novel Coronavirus (COVID-19) Drugs Major Business
Table 20. Philipps University Marburg Medical Center Novel Coronavirus (COVID-19) Drugs Total Revenue (USD Million) (2017-2018)
Table 21. Philipps University Marburg Medical Center SWOT Analysis
Table 22. Philipps University Marburg Medical Center Novel Coronavirus (COVID-19) Drugs Product and Solutions
Table 23. Philipps University Marburg Medical Center Novel Coronavirus (COVID-19) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. King Abdullah International Medical Research Center Corporate Information, Location and Competitors
Table 25. King Abdullah International Medical Research Center Novel Coronavirus (COVID-19) Drugs Major Business
Table 26. King Abdullah International Medical Research Center Novel Coronavirus (COVID-19) Drugs Total Revenue (USD Million) (2017-2018)
Table 27. King Abdullah International Medical Research Center SWOT Analysis
Table 28. King Abdullah International Medical Research Center Novel Coronavirus (COVID-19) Drugs Product and Solutions
Table 29. King Abdullah International Medical Research Center Novel Coronavirus (COVID-19) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Novavax Corporate Information, Location and Competitors
Table 31. Novavax Novel Coronavirus (COVID-19) Drugs Major Business
Table 32. Novavax Novel Coronavirus (COVID-19) Drugs Total Revenue (USD Million) (2017-2018)
Table 33. Novavax SWOT Analysis
Table 34. Novavax Novel Coronavirus (COVID-19) Drugs Product and Solutions
Table 35. Novavax Novel Coronavirus (COVID-19) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. CanSino Biologics Corporate Information, Location and Competitors
Table 37. CanSino Biologics Novel Coronavirus (COVID-19) Drugs Major Business
Table 38. CanSino Biologics Novel Coronavirus (COVID-19) Drugs Total Revenue (USD Million) (2017-2018)
Table 39. CanSino Biologics SWOT Analysis
Table 40. CanSino Biologics Novel Coronavirus (COVID-19) Drugs Product and Solutions
Table 41. CanSino Biologics Novel Coronavirus (COVID-19) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Entos Pharmaceuticals Corporate Information, Location and Competitors
Table 43. Entos Pharmaceuticals Novel Coronavirus (COVID-19) Drugs Major Business
Table 44. Entos Pharmaceuticals Novel Coronavirus (COVID-19) Drugs Total Revenue (USD Million) (2017-2018)
Table 45. Entos Pharmaceuticals SWOT Analysis
Table 46. Entos Pharmaceuticals Novel Coronavirus (COVID-19) Drugs Product and Solutions
Table 47. Entos Pharmaceuticals Novel Coronavirus (COVID-19) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. SAB Biotherapeutics Corporate Information, Location and Competitors
Table 49. SAB Biotherapeutics Novel Coronavirus (COVID-19) Drugs Major Business
Table 50. SAB Biotherapeutics Novel Coronavirus (COVID-19) Drugs Total Revenue (USD Million) (2017-2018)
Table 51. SAB Biotherapeutics SWOT Analysis
Table 52. SAB Biotherapeutics Novel Coronavirus (COVID-19) Drugs Product and Solutions
Table 53. SAB Biotherapeutics Novel Coronavirus (COVID-19) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Naval Medical Research Center Corporate Information, Location and Competitors
Table 55. Naval Medical Research Center Novel Coronavirus (COVID-19) Drugs Major Business
Table 56. Naval Medical Research Center Novel Coronavirus (COVID-19) Drugs Total Revenue (USD Million) (2017-2018)
Table 57. Naval Medical Research Center SWOT Analysis
Table 58. Naval Medical Research Center Novel Coronavirus (COVID-19) Drugs Product and Solutions
Table 59. Naval Medical Research Center Novel Coronavirus (COVID-19) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Inovio Corporate Information, Location and Competitors
Table 61. Inovio Novel Coronavirus (COVID-19) Drugs Major Business
Table 62. Inovio Novel Coronavirus (COVID-19) Drugs Total Revenue (USD Million) (2017-2018)
Table 63. Inovio SWOT Analysis
Table 64. Inovio Novel Coronavirus (COVID-19) Drugs Product and Solutions
Table 65. Inovio Novel Coronavirus (COVID-19) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Global Novel Coronavirus (COVID-19) Drugs Revenue (Million USD) by Players (2015-2020)
Table 67. Global Novel Coronavirus (COVID-19) Drugs Revenue Share by Players (2015-2020)
Table 68. Global Novel Coronavirus (COVID-19) Drugs Revenue (Million USD) by Regions (2015-2020)
Table 69. Global Novel Coronavirus (COVID-19) Drugs Revenue Market Share by Regions (2015-2020)
Table 70. North America Novel Coronavirus (COVID-19) Drugs Revenue by Countries (2015-2020)
Table 71. North America Novel Coronavirus (COVID-19) Drugs Revenue Market Share by Countries (2015-2020)
Table 72. Europe Novel Coronavirus (COVID-19) Drugs Revenue (Million USD) by Countries (2015-2020)
Table 73. Asia-Pacific Novel Coronavirus (COVID-19) Drugs Revenue (Million USD) by Countries (2015-2020)
Table 74. South America Novel Coronavirus (COVID-19) Drugs Revenue by Countries (2015-2020)
Table 75. South America Novel Coronavirus (COVID-19) Drugs Revenue Market Share by Countries (2015-2020)
Table 76. Middle East and Africa Novel Coronavirus (COVID-19) Drugs Revenue (Million USD) by Countries (2015-2020)
Table 77. Middle East and Africa Novel Coronavirus (COVID-19) Drugs Revenue Market Share by Countries (2015-2020)
Table 78. Global Novel Coronavirus (COVID-19) Drugs Revenue (Million USD) by Type (2015-2020)
Table 79. Global Novel Coronavirus (COVID-19) Drugs Revenue Share by Type (2015-2020)
Table 80. Global Novel Coronavirus (COVID-19) Drugs Revenue Forecast by Type (2021-2025)
Table 81. Global Novel Coronavirus (COVID-19) Drugs Revenue by Application (2015-2020)
Table 82. Global Novel Coronavirus (COVID-19) Drugs Revenue Share by Application (2015-2020)
Table 83. Global Novel Coronavirus (COVID-19) Drugs Revenue Forecast by Application (2021-2025)
Table 84. Global Novel Coronavirus (COVID-19) Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Novel Coronavirus (COVID-19) Drugs Picture
Figure 2. Global Novel Coronavirus (COVID-19) Drugs Revenue Market Share by Type in 2019
Figure 3. Vaccine Picture
Figure 4. Tablet Picture
Figure 5. Novel Coronavirus (COVID-19) Drugs Revenue Market Share by Application in 2019
Figure 6. Adults (Non-pregnant) Picture
Figure 7. Pregnant Women Picture
Figure 8. Children Picture
Figure 9. Olders Picture
Figure 10. Global Novel Coronavirus (COVID-19) Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Novel Coronavirus (COVID-19) Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Novel Coronavirus (COVID-19) Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Novel Coronavirus (COVID-19) Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Novel Coronavirus (COVID-19) Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Novel Coronavirus (COVID-19) Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Novel Coronavirus (COVID-19) Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Novel Coronavirus (COVID-19) Drugs Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Novel Coronavirus (COVID-19) Drugs Revenue Market Share in 2019
Figure 19. Global Top 10 Players Novel Coronavirus (COVID-19) Drugs Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Novel Coronavirus (COVID-19) Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Novel Coronavirus (COVID-19) Drugs Revenue Market Share by Regions (2015-2020)
Figure 23. Global Novel Coronavirus (COVID-19) Drugs Revenue Market Share by Regions in 2018
Figure 24. North America Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
Figure 25. Europe Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
Figure 27. South America Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
Figure 29. North America Novel Coronavirus (COVID-19) Drugs Revenue Market Share by Countries (2015-2020)
Figure 30. North America Novel Coronavirus (COVID-19) Drugs Revenue Market Share by Countries in 2019
Figure 31. USA Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
Figure 32. Canada Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
Figure 34. Europe Novel Coronavirus (COVID-19) Drugs Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Novel Coronavirus (COVID-19) Drugs Revenue Market Share by Countries in 2019
Figure 36. Germany Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
Figure 37. UK Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
Figure 38. France Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
Figure 39. Russia Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
Figure 40. Italy Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Novel Coronavirus (COVID-19) Drugs Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Novel Coronavirus (COVID-19) Drugs Revenue Market Share by Countries in 2019
Figure 43. China Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
Figure 44. Japan Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
Figure 45. Korea Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
Figure 46. India Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
Figure 48. South America Novel Coronavirus (COVID-19) Drugs Revenue Market Share by Countries (2015-2020)
Figure 49. South America Novel Coronavirus (COVID-19) Drugs Revenue Market Share by Countries in 2019
Figure 50. Brazil Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Novel Coronavirus (COVID-19) Drugs Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Novel Coronavirus (COVID-19) Drugs Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
Figure 55. UAE Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Novel Coronavirus (COVID-19) Drugs Revenue and Growth Rate (2015-2020)
Figure 58. Global Novel Coronavirus (COVID-19) Drugs Revenue Share by Type (2015-2020)
Figure 59. Global Novel Coronavirus (COVID-19) Drugs Revenue Share by Type in 2019
Figure 60. Global Novel Coronavirus (COVID-19) Drugs Market Share Forecast by Type (2021-2025)
Figure 61. Global Vaccine Revenue Growth Rate (2015-2020)
Figure 62. Global Tablet Revenue Growth Rate (2015-2020)
Figure 63. Global Novel Coronavirus (COVID-19) Drugs Revenue Share by Application (2015-2020)
Figure 64. Global Novel Coronavirus (COVID-19) Drugs Revenue Share by Application in 2019
Figure 65. Global Novel Coronavirus (COVID-19) Drugs Market Share Forecast by Application (2021-2025)
Figure 66. Global Adults (Non-pregnant) Revenue Growth Rate (2015-2020)
Figure 67. Global Pregnant Women Revenue Growth Rate (2015-2020)
Figure 68. Global Children Revenue Growth Rate (2015-2020)
Figure 69. Global Olders Revenue Growth Rate (2015-2020)
Figure 70. Global Novel Coronavirus (COVID-19) Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Novel Coronavirus (COVID-19) Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Novel Coronavirus (COVID-19) Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Novel Coronavirus (COVID-19) Drugs Revenue Market Forecast (2021-2025)
Figure 74. Europe Novel Coronavirus (COVID-19) Drugs Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Novel Coronavirus (COVID-19) Drugs Revenue Market Forecast (2021-2025)
Figure 76. South America Novel Coronavirus (COVID-19) Drugs Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Novel Coronavirus (COVID-19) Drugs Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel

---